Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025
— HUTCHMED will host in-person presentation and online webinar on Friday, October…
SERES Posts Robust H1 2025 Results: Revenue Hits CNY 62.4 Billion, Net Profit Up 81% to CNY 2.94 Billion, R&D Investment Soars nearly 155%
CHONGQING, China, Sept. 3, 2025 /PRNewswire/ -- On August 29, SERES announced its…
CAS SciFinder integrates transformative new science-smart AI capabilities to enhance R&D efficiency and boost innovation
Pioneering solution provides scientists with actionable answers faster to accelerate scientific discovery…
TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities
July 24, 2025 07:00 ET | Source: TCG Labs Soleil SAN FRANCISCO,…
Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University of Tbingen
TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT)…
Medical Device Manufacturers Accelerate R&D and Speed to Market via Live Prototyping
BOSTON, July 10, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development…
Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241
PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed…
